Trimble Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Trimble Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2023-12-29 | 2022-12-30 | 2021-12-31 | 2020-01-01 | 2018-12-28 | 2017-12-29 | 2016-12-30 | 2015-01-01 | 2014-01-02 | 2012-12-28 | 2011-12-30 | 2011-09-30 | 2011-07-01 | 2011-04-01 | 2010-12-31 | 2010-10-01 | 2010-07-02 | 2010-04-02 | 2010-01-01 | 2009-10-02 | 2009-07-03 | 2009-04-03 | 2009-01-02 | 2008-09-26 | 2008-06-27 | 2008-03-28 | 2007-12-28 | 2007-09-28 | 2007-06-29 | 2007-03-30 | 2006-12-29 | 2006-09-29 | 2006-06-30 | 2006-03-31 | 2005-12-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flow from operating activities: | |||||||||||||||||||||||||||||||||||
net income | 63,000,000 | 85,600,000 | 115,300,000 | 155,500,000 | 86,800,000 | -34,900,000 | 37,700,000 | -37,327,000 | 55,383,000 | 32,679,000 | 28,663,000 | 27,196,000 | 54,178,000 | 38,872,000 | 35,848,000 | 32,842,000 | 6,771,000 | 28,152,000 | 9,269,000 | 15,847,000 | 21,150,000 | 17,697,000 | 13,739,000 | 39,067,000 | 48,599,000 | 40,067,000 | 26,291,000 | 27,374,000 | 35,026,000 | 28,683,000 | 23,985,000 | 25,342,000 | 28,503,000 | 25,828,000 | |
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||||||||||||
depreciation and amortization | |||||||||||||||||||||||||||||||||||
deferred income taxes | -600,000 | 1,300,000 | -18,000,000 | -57,300,000 | 1,600,000 | -800,000 | 2,093,000 | 11,870,000 | -2,015,000 | -16,130,000 | -6,036,000 | -2,746,000 | -1,393,000 | -11,091,000 | 634,000 | -4,564,000 | 103,000 | 1,795,000 | -5,862,000 | -1,800,000 | -1,606,000 | -3,121,000 | -885,000 | 12,915,000 | 2,089,000 | -2,234,000 | -6,402,000 | 10,723,000 | 1,323,000 | 202,000 | -1,880,000 | ||||
stock-based compensation | 32,900,000 | 27,200,000 | 27,500,000 | 30,900,000 | 23,800,000 | 19,800,000 | 12,600,000 | 17,975,000 | 17,240,000 | 9,032,000 | 7,418,000 | 7,106,000 | 7,129,000 | 6,798,000 | 6,960,000 | 5,540,000 | 4,984,000 | 5,641,000 | 5,338,000 | 4,541,000 | 4,554,000 | 4,226,000 | 4,563,000 | 3,826,000 | 3,795,000 | 3,982,000 | 4,067,000 | 3,804,000 | 3,792,000 | 3,353,000 | 3,134,000 | 2,948,000 | 3,259,000 | 3,230,000 | |
divestitures gain | 1,400,000 | 4,100,000 | |||||||||||||||||||||||||||||||||
other | 17,500,000 | 19,000,000 | 13,500,000 | 12,200,000 | -200,000 | 300,000 | 1,000,000 | 5,832,000 | -3,111,000 | 675,000 | 2,153,000 | 189,000 | -401,000 | 44,000 | 6,000 | 32,000 | 66,000 | 1,000 | -2,657,000 | 134,000 | -527,000 | 14,000 | -194,000 | -291,000 | 180,000 | -43,000 | 290,000 | -17,000 | 225,000 | 153,000 | 589,000 | -131,000 | -166,000 | 428,000 | |
increase in assets: | |||||||||||||||||||||||||||||||||||
accounts receivable | -60,400,000 | -68,600,000 | -42,700,000 | -30,800,000 | -35,200,000 | -7,400,000 | 11,100,000 | 13,042,000 | 17,584,000 | 15,108,000 | 11,243,000 | -12,467,000 | 9,974,000 | -40,624,000 | 9,654,000 | -1,632,000 | 16,148,000 | -31,546,000 | -6,548,000 | -1,504,000 | 22,829,000 | -18,712,000 | 49,644,000 | -39,280,000 | 7,275,000 | -1,139,000 | -13,570,000 | -28,262,000 | 7,644,000 | -412,000 | 6,794,000 | -26,211,000 | |||
inventories | 21,300,000 | -14,000,000 | -44,500,000 | -6,700,000 | -16,000,000 | -19,300,000 | -1,700,000 | 24,334,000 | -34,423,000 | -3,752,000 | -18,795,000 | 4,756,000 | -7,383,000 | -8,717,000 | -13,000,000 | -12,802,000 | -10,306,000 | -9,441,000 | 11,992,000 | 8,856,000 | -229,000 | -7,327,000 | -296,000 | -3,437,000 | -3,166,000 | -3,752,000 | -10,735,000 | -1,025,000 | 3,068,000 | -582,000 | -8,730,000 | 5,870,000 | |||
other current and non-current assets | -31,700,000 | -14,600,000 | 12,300,000 | -7,900,000 | -6,900,000 | 2,800,000 | 9,900,000 | 5,329,000 | 15,664,000 | -5,101,000 | 3,514,000 | 5,527,000 | -3,449,000 | 4,927,000 | 1,891,000 | -637,000 | 3,106,000 | -2,103,000 | -2,535,000 | -374,000 | 1,559,000 | 730,000 | 980,000 | -191,000 | 1,297,000 | -3,061,000 | -1,753,000 | 11,167,000 | -11,565,000 | -5,030,000 | 4,730,000 | -6,827,000 | |||
increase in liabilities: | |||||||||||||||||||||||||||||||||||
accounts payable | -17,400,000 | -21,000,000 | 9,500,000 | -29,300,000 | -11,200,000 | -1,900,000 | 8,200,000 | 345,000 | 15,282,000 | 18,157,000 | -6,349,000 | -6,737,000 | -7,601,000 | 16,377,000 | -2,219,000 | -1,519,000 | -10,004,000 | 27,319,000 | 3,699,000 | -5,858,000 | -7,892,000 | 12,682,000 | -19,039,000 | -6,496,000 | 877,000 | 3,760,000 | 3,997,000 | -1,220,000 | -9,563,000 | 3,265,000 | 1,763,000 | -7,636,000 | -2,975,000 | 4,361,000 | |
accrued compensation and benefits | 8,500,000 | -1,300,000 | 29,000,000 | 87,200,000 | 32,400,000 | 26,200,000 | 13,400,000 | 9,221,000 | 3,265,000 | 1,514,000 | 4,390,000 | 3,532,000 | 4,788,000 | -10,241,000 | 148,000 | 7,638,000 | 3,401,000 | 4,741,000 | -2,028,000 | -535,000 | 417,000 | 2,391,000 | -5,061,000 | -10,557,000 | -11,618,000 | 5,619,000 | 1,003,000 | 7,786,000 | -6,601,000 | ||||||
deferred revenue | 65,700,000 | 94,300,000 | 35,800,000 | 32,300,000 | 22,500,000 | -13,200,000 | -6,700,000 | -13,761,000 | -1,026,000 | 4,170,000 | 11,137,000 | -950,000 | 9,807,000 | -1,219,000 | -3,159,000 | 1,306,000 | -4,792,000 | 5,468,000 | 14,723,000 | 3,529,000 | 3,117,000 | 4,107,000 | -4,182,000 | -1,112,000 | 1,940,000 | 2,034,000 | 13,857,000 | 8,836,000 | 3,296,000 | -363,000 | 4,452,000 | 5,410,000 | |||
income taxes payable | -66,500,000 | -15,394,000 | 5,187,000 | -2,454,000 | 12,547,000 | -14,958,000 | -119,000 | 20,668,000 | 12,962,000 | 2,750,000 | -142,000 | 288,000 | 7,336,000 | ||||||||||||||||||||||
other current and non-current liabilities | -200,000 | -49,700,000 | -26,000,000 | -39,300,000 | |||||||||||||||||||||||||||||||
net cash from operating activities | 98,900,000 | 106,100,000 | 155,300,000 | 209,200,000 | 101,900,000 | 101,900,000 | 125,100,000 | 44,436,000 | 128,675,000 | 96,806,000 | 79,808,000 | 51,105,000 | 82,789,000 | 27,927,000 | 36,998,000 | -8,277,000 | 39,806,000 | 55,503,000 | 55,510,000 | 30,447,000 | 65,513,000 | 43,161,000 | 34,129,000 | 41,582,000 | 79,644,000 | 20,719,000 | 57,901,000 | 42,627,000 | 54,710,000 | 31,747,000 | 52,320,000 | 26,398,000 | 42,492,000 | 16,877,000 | |
capex | -9,800,000 | -6,600,000 | -14,700,000 | 0 | -14,500,000 | -17,300,000 | -6,300,000 | -8,948,000 | 10,334,000 | -19,945,000 | -7,276,000 | -6,680,000 | -5,286,000 | -4,036,000 | -5,971,000 | -6,132,000 | -5,731,000 | -5,299,000 | 0 | -2,126,000 | -4,154,000 | -3,261,000 | 0 | 0 | 0 | -3,711,000 | 0 | -2,938,000 | 0 | -3,873,000 | -2,563,000 | -3,023,000 | -5,971,000 | -4,972,000 | |
free cash flows | 89,100,000 | 99,500,000 | 140,600,000 | 209,200,000 | 87,400,000 | 84,600,000 | 118,800,000 | 35,488,000 | 139,009,000 | 76,861,000 | 72,532,000 | 44,425,000 | 77,503,000 | 23,891,000 | 31,027,000 | -14,409,000 | 34,075,000 | 50,204,000 | 55,510,000 | 28,321,000 | 61,359,000 | 39,900,000 | 34,129,000 | 41,582,000 | 79,644,000 | 17,008,000 | 57,901,000 | 39,689,000 | 54,710,000 | 27,874,000 | 49,757,000 | 23,375,000 | 36,521,000 | 11,905,000 | |
cash flow from investing activities: | |||||||||||||||||||||||||||||||||||
divestiture of businesses, net of cash divested | |||||||||||||||||||||||||||||||||||
acquisitions of businesses, net of cash acquired | 0 | -55,400,000 | -234,900,000 | -173,300,000 | -22,100,000 | -6,400,000 | -16,500,000 | 14,563,000 | -107,544,000 | -372,630,000 | -1,494,000 | -666,794,000 | -52,470,000 | -38,979,000 | -45,662,000 | -57,152,000 | -12,034,000 | -21,571,000 | -1,194,000 | -11,795,000 | -21,735,000 | -17,294,000 | -45,827,000 | -39,593,000 | -10,325,000 | -7,780,000 | |||||||||
purchases of property and equipment | -9,800,000 | -6,600,000 | -14,700,000 | ||||||||||||||||||||||||||||||||
net cash from investing activities | -3,700,000 | -74,100,000 | -254,500,000 | -163,100,000 | -36,800,000 | -43,100,000 | -65,800,000 | 30,043,000 | -87,638,000 | -376,324,000 | -1,719,000 | -677,385,000 | -51,240,000 | -43,221,000 | -47,237,000 | -48,429,000 | -30,792,000 | -29,916,000 | 2,761,000 | -12,891,000 | -27,254,000 | -46,542,000 | -44,087,000 | -43,347,000 | -19,910,000 | -8,428,000 | -7,143,000 | -275,911,000 | -59,283,000 | -8,069,000 | -41,836,000 | -7,244,000 | |||
cash flow from financing activities: | |||||||||||||||||||||||||||||||||||
issuance of common stock, net of tax withholdings | -1,300,000 | -8,800,000 | -16,200,000 | -18,400,000 | -12,100,000 | 800,000 | |||||||||||||||||||||||||||||
repurchases of common stock | 0 | -40,000,000 | |||||||||||||||||||||||||||||||||
proceeds from debt and revolving credit lines | 448,300,000 | 285,500,000 | 0 | 355,800,000 | 384,400,000 | 269,000,000 | 64,000,000 | 512,973,000 | 544,145,000 | ||||||||||||||||||||||||||
payments on debt and revolving credit lines | -436,100,000 | -354,300,000 | -28,200,000 | -452,400,000 | -425,700,000 | -51,100,000 | -114,000,000 | -401,926,000 | -459,240,000 | ||||||||||||||||||||||||||
net cash from financing activities | -89,200,000 | -84,000,000 | -84,500,000 | -23,100,000 | -93,600,000 | 44,900,000 | -48,300,000 | -94,270,000 | 10,871,000 | 295,098,000 | -63,996,000 | 520,156,000 | -27,463,000 | 35,470,000 | 20,300,000 | 9,077,000 | 1,316,000 | 8,879,000 | 1,307,000 | 4,623,000 | 90,760,000 | -15,707,000 | -17,260,000 | -23,097,000 | -38,494,000 | 182,667,000 | 11,100,000 | ||||||||
effect of exchange rate changes on cash and cash equivalents | 10,000,000 | 14,300,000 | -3,800,000 | 13,400,000 | -4,400,000 | -200,000 | -8,400,000 | -4,459,000 | -8,621,000 | 351,000 | 2,273,000 | -5,432,000 | 1,383,000 | 3,378,000 | -329,000 | 5,241,000 | -4,025,000 | -1,439,000 | -838,000 | 3,510,000 | 3,761,000 | -1,946,000 | -3,750,000 | -4,926,000 | -1,444,000 | 6,512,000 | -1,601,000 | -790,000 | 1,116,000 | -4,553,000 | -2,669,000 | 191,000 | -633,000 | 3,062,000 | |
net increase in cash and cash equivalents | -37,700,000 | -187,500,000 | 36,400,000 | -32,900,000 | 103,500,000 | 2,600,000 | 5,469,000 | 23,554,000 | 9,732,000 | -50,604,000 | -45,413,000 | 33,225,000 | 58,749,000 | 29,945,000 | 19,130,000 | 10,312,000 | 10,189,000 | -66,050,000 | -6,781,000 | 28,676,000 | 10,078,000 | 23,795,000 | -13,440,000 | ||||||||||||
cash and cash equivalents - beginning of period | 0 | ||||||||||||||||||||||||||||||||||
cash and cash equivalents - end of period | 16,000,000 | ||||||||||||||||||||||||||||||||||
supplemental cash flow disclosure: | |||||||||||||||||||||||||||||||||||
cash paid for income taxes, excluding tax for the ag divestiture | |||||||||||||||||||||||||||||||||||
cash tax paid for the ag divestiture | |||||||||||||||||||||||||||||||||||
non-cash equity investments | |||||||||||||||||||||||||||||||||||
includes 9.0 million and 9.1 million of cash and cash equivalents classified as held for sale as of january 3, 2025 and december 29, 2023. | |||||||||||||||||||||||||||||||||||
cash paid for income taxes | |||||||||||||||||||||||||||||||||||
includes 9.0 million, 6.5 million, and 9.1 million of cash and cash equivalents classified as held for sale as of january 3, 2025, march 29, 2024, and december 29, 2023. | |||||||||||||||||||||||||||||||||||
proceeds from divestitures | |||||||||||||||||||||||||||||||||||
cash tax paid, net, excluding tax for the ag divestiture | |||||||||||||||||||||||||||||||||||
includes 17.1 million, 9.1 million, and 6.1 million of cash and cash equivalents classified as held for sale as of september 27, 2024, december 29, 2023, and september 29, 2023. | |||||||||||||||||||||||||||||||||||
includes 9.1 million of cash and cash equivalents classified as held for sale as of december 29, 2023. | |||||||||||||||||||||||||||||||||||
include 6.5 million and 9.1 million of cash and cash equivalents classified as held for sale as of march 29, 2024 and december 29, 2023. | |||||||||||||||||||||||||||||||||||
cash paid for interest | |||||||||||||||||||||||||||||||||||
non-cash equity investment | |||||||||||||||||||||||||||||||||||
depreciation expense | 8,800,000 | 10,100,000 | 10,400,000 | 10,000,000 | 9,400,000 | 8,200,000 | 9,100,000 | 12,632,000 | 13,499,000 | 6,781,000 | 5,826,000 | 5,508,000 | 4,572,000 | 4,603,000 | 4,888,000 | 4,574,000 | 4,285,000 | 4,451,000 | 4,870,000 | 4,608,000 | 4,463,000 | 5,013,000 | 4,703,000 | 4,571,000 | 4,307,000 | 4,305,000 | 4,121,000 | 3,450,000 | 3,385,000 | 3,104,000 | |||||
amortization expense | 56,600,000 | 33,700,000 | 33,500,000 | 29,200,000 | 46,700,000 | 39,700,000 | 33,600,000 | 44,631,000 | 37,799,000 | 36,392,000 | 28,413,000 | 24,106,000 | 16,576,000 | 16,065,000 | 15,474,000 | 14,432,000 | 13,916,000 | 13,817,000 | 13,620,000 | 13,050,000 | 12,298,000 | 11,188,000 | 10,963,000 | 10,848,000 | 10,221,000 | 10,500,000 | 7,894,000 | 2,937,000 | 3,765,000 | 2,380,000 | |||||
net proceeds from divestitures | 1,900,000 | 1,100,000 | |||||||||||||||||||||||||||||||||
net decrease in cash and cash equivalents | -704,000 | -31,823,000 | |||||||||||||||||||||||||||||||||
change in fair value of derivatives | |||||||||||||||||||||||||||||||||||
cash flows from operating activities | |||||||||||||||||||||||||||||||||||
cash flows from financing activities: | |||||||||||||||||||||||||||||||||||
cash and cash equivalents - beginning of year | |||||||||||||||||||||||||||||||||||
cash and cash equivalents - end of year | |||||||||||||||||||||||||||||||||||
net proceeds from sale of property and equipment | 100,000 | ||||||||||||||||||||||||||||||||||
net proceeds from sale of businesses | 0 | ||||||||||||||||||||||||||||||||||
divestitures (gain) loss | -300,000 | ||||||||||||||||||||||||||||||||||
repurchase of common stock | |||||||||||||||||||||||||||||||||||
benefit from credit losses | |||||||||||||||||||||||||||||||||||
income from equity method investments, net of dividends | |||||||||||||||||||||||||||||||||||
benefit from doubtful accounts | 0 | 500,000 | -987,000 | 2,543,000 | 602,000 | 959,000 | 314,000 | 281,000 | 359,000 | -702,000 | 426,000 | 1,558,000 | 1,038,000 | 1,206,000 | -120,000 | 841,000 | 2,212,000 | 2,112,000 | 478,000 | 81,000 | 38,000 | 726,000 | 326,000 | 70,000 | 288,000 | -18,000 | 86,000 | -265,000 | 360,000 | ||||||
non-cash restructuring expense | 1,391,000 | ||||||||||||||||||||||||||||||||||
benefit from excess and obsolete inventories | 1,900,000 | 3,800,000 | 8,747,000 | 3,266,000 | -138,000 | 1,495,000 | 2,184,000 | 2,242,000 | 2,489,000 | 1,179,000 | 400,000 | 1,271,000 | 1,902,000 | 587,000 | 10,000 | 2,029,000 | 904,000 | 1,754,000 | -611,000 | 1,180,000 | 2,103,000 | 839,000 | 1,572,000 | ||||||||||||
acquisitions of property and equipment | -14,500,000 | -17,300,000 | -6,300,000 | -8,948,000 | 10,334,000 | -19,945,000 | -7,276,000 | -6,680,000 | -5,286,000 | -4,036,000 | -5,971,000 | -6,132,000 | -5,731,000 | -5,299,000 | -2,126,000 | -4,154,000 | -3,261,000 | -3,711,000 | -2,938,000 | ||||||||||||||||
(income) income from equity method investments, net of dividends | |||||||||||||||||||||||||||||||||||
purchases of short-term investments | 0 | -68,000,000 | |||||||||||||||||||||||||||||||||
proceeds from maturities of short-term investments | 0 | 37,500,000 | |||||||||||||||||||||||||||||||||
proceeds from sales of short-term investments | 0 | 5,600,000 | |||||||||||||||||||||||||||||||||
cash and cash equivalents - beginning of fiscal year | |||||||||||||||||||||||||||||||||||
cash and cash equivalents - end of fiscal year | |||||||||||||||||||||||||||||||||||
income from equity method investments | 2,100,000 | -6,700,000 | -3,700,000 | -6,372,000 | 3,540,000 | -5,019,000 | -3,418,000 | -2,763,000 | -2,770,000 | -3,404,000 | |||||||||||||||||||||||||
other non-cash items | 7,800,000 | 6,700,000 | -600,000 | 4,578,000 | 3,915,000 | -1,202,000 | 147,000 | 707,000 | 1,454,000 | 577,000 | -980,000 | -296,000 | -1,574,000 | -1,760,000 | -182,000 | -302,000 | -2,058,000 | 178,000 | -201,000 | 202,000 | 4,000 | ||||||||||||||
cash flows from operating activities: | |||||||||||||||||||||||||||||||||||
add decrease (increase) in assets: | |||||||||||||||||||||||||||||||||||
add increase in liabilities: | |||||||||||||||||||||||||||||||||||
other liabilities | -60,300,000 | ||||||||||||||||||||||||||||||||||
cash flows from investing activities: | |||||||||||||||||||||||||||||||||||
cash and cash equivalents, beginning of fiscal year | |||||||||||||||||||||||||||||||||||
cash and cash equivalents, end of fiscal year | |||||||||||||||||||||||||||||||||||
decrease (increase) in assets: | |||||||||||||||||||||||||||||||||||
other receivables | 2,900,000 | 4,100,000 | 13,209,000 | -6,368,000 | 2,979,000 | 16,670,000 | 7,483,000 | 212,000 | 5,776,000 | 2,327,000 | -7,456,000 | -413,000 | 8,060,000 | -2,772,000 | 1,046,000 | -244,000 | 5,486,000 | -9,020,000 | 1,117,000 | -35,000 | 516,000 | 206,000 | 1,651,000 | 1,101,000 | 1,867,000 | 2,572,000 | 2,026,000 | -3,176,000 | 527,000 | ||||||
accrued warranty expense | 2,698,000 | 971,000 | 242,000 | ||||||||||||||||||||||||||||||||
accrued liabilities | 8,377,000 | -5,958,000 | -1,234,000 | 4,398,000 | 218,000 | -3,371,000 | -24,297,000 | 2,617,000 | 2,486,000 | -6,644,000 | 2,790,000 | 5,801,000 | 2,458,000 | -1,648,000 | -3,803,000 | -4,048,000 | 1,153,000 | 2,063,000 | 7,218,000 | 4,872,000 | -5,641,000 | 3,503,000 | |||||||||||||
purchases of equity method investments | 0 | 0 | -3,000,000 | -2,750,000 | |||||||||||||||||||||||||||||||
net proceeds from sales of businesses | 0 | ||||||||||||||||||||||||||||||||||
dividends received from equity method investments | 5,200,000 | 1,100,000 | -5,850,000 | 24,559,000 | |||||||||||||||||||||||||||||||
divestiture (gain) loss | |||||||||||||||||||||||||||||||||||
accrued warranty | |||||||||||||||||||||||||||||||||||
acquisitions of intangible assets | 0 | 6,907,000 | -375,000 | 0 | -1,100,000 | -316,000 | -250,000 | -1,438,000 | -328,000 | 0 | -297,000 | 0 | 0 | -838,000 | -26,001,000 | ||||||||||||||||||||
repurchases and retirement of common stock | |||||||||||||||||||||||||||||||||||
divestiture gain | |||||||||||||||||||||||||||||||||||
gain on an equity sale | |||||||||||||||||||||||||||||||||||
excess tax benefit for stock-based compensation | -1,500,000 | 11,994,000 | -5,295,000 | -8,672,000 | -3,064,000 | -748,000 | -2,593,000 | -8,357,000 | -7,668,000 | -559,000 | -930,000 | -482,000 | -149,000 | -1,000,000 | -283,000 | -21,000 | -123,000 | -11,096,000 | 7,241,000 | -1,992,000 | 874,000 | -7,354,000 | -3,736,000 | -2,193,000 | -673,000 | -3,318,000 | -829,000 | -3,941,000 | |||||||
repurchase and retirement of common stock | -17,300,000 | -169,422,000 | 0 | -13,343,000 | -10,037,000 | -25,870,000 | |||||||||||||||||||||||||||||
purchases of available-for-sale investments | |||||||||||||||||||||||||||||||||||
issuances of common stock, net of tax withholdings | |||||||||||||||||||||||||||||||||||
cash and cash equivalents, beginning of period | 0 | 0 | 220,788,000 | 0 | 0 | 273,848,000 | -5,000,000 | 0 | 147,531,000 | 0 | 0 | 103,202,000 | 0 | 0 | 129,621,000 | 0 | 0 | 73,853,000 | |||||||||||||||||
cash and cash equivalents, end of period | -111,556,000 | 5,469,000 | 244,342,000 | -50,604,000 | -45,413,000 | 307,073,000 | 24,945,000 | 43,327,000 | 146,827,000 | -9,344,000 | 8,444,000 | 71,379,000 | 10,312,000 | 10,189,000 | 63,571,000 | 28,676,000 | 10,078,000 | 97,648,000 | |||||||||||||||||
acquisition / divestiture gain | |||||||||||||||||||||||||||||||||||
purchases of equity investments | |||||||||||||||||||||||||||||||||||
net proceeds from sale of business | |||||||||||||||||||||||||||||||||||
dividends received from equity investments | |||||||||||||||||||||||||||||||||||
issuances of common stock, net of tax withholding | |||||||||||||||||||||||||||||||||||
payments related to repurchases of common stock | |||||||||||||||||||||||||||||||||||
acquisition / divestiture (gain)/loss | |||||||||||||||||||||||||||||||||||
(purchases) sales of equity method investments | 5,439,000 | ||||||||||||||||||||||||||||||||||
increase in restricted cash | |||||||||||||||||||||||||||||||||||
issuances of common stock | 9,519,000 | 2,878,000 | 27,785,000 | 14,018,000 | 9,218,000 | 8,649,000 | 7,898,000 | 1,173,000 | 4,602,000 | 6,694,000 | 6,942,000 | 8,483,000 | 12,069,000 | ||||||||||||||||||||||
sale of equity method investments | |||||||||||||||||||||||||||||||||||
dividends received | 11,038,000 | 4,898,000 | 0 | 858,000 | 0 | 2,307,000 | |||||||||||||||||||||||||||||
proceeds from long-term debt and revolving credit lines | 720,796,000 | 32,000,000 | 100,000,000 | 0 | 0 | 0 | 250,000,000 | ||||||||||||||||||||||||||||
payments on short-term and long-term debt | -104,747,000 | -48,111,000 | |||||||||||||||||||||||||||||||||
proceeds received from noncontrolling interest holder | |||||||||||||||||||||||||||||||||||
issuance of common stock | 10,474,000 | 6,972,000 | 10,013,000 | 7,149,000 | |||||||||||||||||||||||||||||||
payments on long-term debt and revolving credit lines | -672,000 | -32,000 | -373,000 | -40,000 | -54,000 | -15,000 | -19,000 | 2,000 | -2,000 | -60,002,000 | -312,000 | -20,420,000 | -42,520,000 | -47,517,000 | -80,000,000 | ||||||||||||||||||||
net maturities of short term investments | |||||||||||||||||||||||||||||||||||
(income) income from equity method investments | |||||||||||||||||||||||||||||||||||
income tax payable | |||||||||||||||||||||||||||||||||||
increase in restricted cash for business acquisition | |||||||||||||||||||||||||||||||||||
proceeds from long-term debt, net of debt issuance costs | |||||||||||||||||||||||||||||||||||
net (purchases) maturities of short term investments | |||||||||||||||||||||||||||||||||||
purchase of equity method investments | -2,000,000 | ||||||||||||||||||||||||||||||||||
net purchases of short term investments | |||||||||||||||||||||||||||||||||||
net purchases of debt and equity securities | |||||||||||||||||||||||||||||||||||
net cash provided (used) by financing activities | |||||||||||||||||||||||||||||||||||
loss (income) from equity method investments | -2,474,000 | ||||||||||||||||||||||||||||||||||
depreciation | |||||||||||||||||||||||||||||||||||
amortization | |||||||||||||||||||||||||||||||||||
amortization of debt issuance cost | 57,000 | 56,000 | 56,000 | 57,000 | 45,000 | 45,000 | |||||||||||||||||||||||||||||
in-process research and development | 0 | 0 | 0 | 2,112,000 | 930,000 | -20,000 | |||||||||||||||||||||||||||||
equity gain from joint ventures | |||||||||||||||||||||||||||||||||||
acquisition of property and equipment | -3,873,000 | -2,563,000 | -3,023,000 | -5,971,000 | -4,972,000 | ||||||||||||||||||||||||||||||
net (purchases) maturities of debt and equity securities | |||||||||||||||||||||||||||||||||||
investment in joint venture | |||||||||||||||||||||||||||||||||||
capital infusion from minority investor | |||||||||||||||||||||||||||||||||||
proceeds from dividends | |||||||||||||||||||||||||||||||||||
issuance of common stock and warrants | |||||||||||||||||||||||||||||||||||
amortization of debt issuance costs | 56,000 | 57,000 | 56,000 | ||||||||||||||||||||||||||||||||
income from joint ventures | 151,000 | -352,000 | -168,000 | ||||||||||||||||||||||||||||||||
gain on bargain purchase | 0 | ||||||||||||||||||||||||||||||||||
net purchases of short-term investments | |||||||||||||||||||||||||||||||||||
purchase of debt and equity securities | |||||||||||||||||||||||||||||||||||
non-cash restructuring charges | 0 | ||||||||||||||||||||||||||||||||||
equity gain from joint venture | -2,015,000 | -1,942,000 | |||||||||||||||||||||||||||||||||
equity (gain) income from joint ventures | |||||||||||||||||||||||||||||||||||
deferred gain on joint venture | |||||||||||||||||||||||||||||||||||
deferred revenues | |||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities | |||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash | |||||||||||||||||||||||||||||||||||
provided by operating activities: | |||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities, net of effect of acquisitions: | |||||||||||||||||||||||||||||||||||
excess and obsolescence reserve | 1,055,000 | ||||||||||||||||||||||||||||||||||
gain from joint ventures | -2,423,000 | ||||||||||||||||||||||||||||||||||
acquisitions, net of cash acquired | -272,050,000 | -56,720,000 | -5,030,000 | ||||||||||||||||||||||||||||||||
costs of capitalized patents | |||||||||||||||||||||||||||||||||||
net cash provided (used) in financing activities | 10,156,000 | ||||||||||||||||||||||||||||||||||
changes in assets and liabilities: | |||||||||||||||||||||||||||||||||||
cost of acquisitions, net of cash acquired | -2,272,000 | ||||||||||||||||||||||||||||||||||
collection of notes receivable | 10,000 | ||||||||||||||||||||||||||||||||||
cash and cash equivalents | |||||||||||||||||||||||||||||||||||
as a percentage of total assets | |||||||||||||||||||||||||||||||||||
accounts receivable days sales outstanding | |||||||||||||||||||||||||||||||||||
inventory turns per year | |||||||||||||||||||||||||||||||||||
total debt | |||||||||||||||||||||||||||||||||||
cash from operating activities | |||||||||||||||||||||||||||||||||||
cash from investing activities | |||||||||||||||||||||||||||||||||||
cash provided (used) by financing activities | |||||||||||||||||||||||||||||||||||
other uses of cash | |||||||||||||||||||||||||||||||||||
dividends received from joint venture | |||||||||||||||||||||||||||||||||||
proceeds from sale of assets |
We provide you with 20 years of cash flow statements for Trimble stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Trimble stock. Explore the full financial landscape of Trimble stock with our expertly curated income statements.
The information provided in this report about Trimble stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.